{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:20:38Z","timestamp":1791300038957,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Association Francaise contre les Myopathies","award":["80077"],"award-info":[{"award-number":["80077"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jneuroim.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T17:30:46Z","timestamp":1504719046000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis"],"prefix":"10.1016","volume":"312","author":[{"given":"Konstantinos","family":"Lazaridis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Dalianoudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Baltatzidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2017.09.001_bb0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1684\/ejd.2011.1169","article-title":"Catabolism of pemphigus foliaceus autoantibodies by high-dose IVIg therapy","volume":"21","author":"Aoyama","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2008.05.026","article-title":"Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients","volume":"201-202","author":"Baggi","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.2042-7158.1997.tb06795.x","article-title":"Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab')2 and Fab after intravenous administration in the rat","volume":"49","author":"Bazin-Redureau","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0020","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/039139889401701109","article-title":"Removal of antiacetylcholine receptor antibodies by protein-a immunoadsorption in myasthenia gravis","volume":"17","author":"Berta","year":"1994","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0025","doi-asserted-by":"crossref","first-page":"419520","DOI":"10.1155\/2010\/419520","article-title":"Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravis","volume":"2010","author":"Blaha","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jca.10035","article-title":"Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis","volume":"17","author":"Bosch","year":"2002","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0035","doi-asserted-by":"crossref","first-page":"40207","DOI":"10.1074\/jbc.R112.407668","article-title":"The nicotinic acetylcholine receptor: the founding father of the pentameric ligand-gated ion channel superfamily","volume":"287","author":"Changeux","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0040","article-title":"Myasthenia gravis: a review of available treatment approaches","volume":"2011","author":"Gilhus","year":"2011","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0050","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.ajpath.2016.05.025","article-title":"Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis","volume":"186","author":"Gomez","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molimm.2015.03.255","article-title":"Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases","volume":"67","author":"Irani","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1046\/j.1525-1594.1998.06010.x","article-title":"Clinical trials of type I and in vitro studies of type II immunoadsorbents for systemic lupus erythematosus therapy","volume":"22","author":"Kong","year":"1998","journal-title":"Artif. Organs"},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2007.07.018","article-title":"Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency","volume":"190","author":"Kostelidou","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.11.001","article-title":"Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies","volume":"267","author":"Lagoumintzis","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijbiomac.2013.11.003","article-title":"Expression of human AChR extracellular domain mutants with improved characteristics","volume":"63","author":"Lazaridis","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2014.12.001","article-title":"Specific adsorbents for myasthenia gravis autoantibodies using mutants of the muscle nicotinic acetylcholine receptor extracellular domains","volume":"278","author":"Lazaridis","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2016.12.011","article-title":"Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains","volume":"303","author":"Lazaridis","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0090","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1084\/jem.144.3.726","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"issue":"74 Pt C","key":"10.1016\/j.jneuroim.2017.09.001_bb0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0076-6879(81)74031-X","article-title":"Production and assay of antibodies to acetylcholine receptors","author":"Lindstrom","year":"1981","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2015.03.010","article-title":"Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo Californica acetylcholine receptors\u2014recommendations for methods and experimental designs","volume":"270","author":"Losen","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0110","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1523\/JNEUROSCI.2833-09.2009","article-title":"Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity","volume":"29","author":"Luo","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/IJGM.S88552","article-title":"Animal models of myasthenia gravis: utility and limitations","volume":"9","author":"Mantegazza","year":"2016","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0120","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2353\/ajpath.2007.060676","article-title":"Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis","volume":"170","author":"Martinez-Martinez","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0125","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/jaut.1993.1057","article-title":"Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg","volume":"6","author":"Masson","year":"1993","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1526-0968.2001.00370.x","article-title":"Background and indications for protein A-based extracorporeal immunoadsorption","volume":"5","author":"Matic","year":"2001","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0135","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(79)90823-7","article-title":"Long-term effects of repeated plasma exchange in myasthenia gravis","volume":"1","author":"Newsom-Davis","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0145","first-page":"683","article-title":"The biological half-lives of four rat immunoglobulin isotypes","volume":"40","author":"Peppard","year":"1980","journal-title":"Immunology"},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","article-title":"Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy","volume":"159","author":"Psaridi-Linardaki","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.transci.2003.11.005","article-title":"Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis","volume":"30","author":"Ptak","year":"2004","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0160","first-page":"164","article-title":"Removal kinetics of therapeutic apheresis","volume":"5","author":"Reverberi","year":"2007","journal-title":"Blood Transfus."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0165","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0170","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/08916930903518107","article-title":"Immunosuppressive therapies in myasthenia gravis","volume":"43","author":"Sanders","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0175","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-4159.2010.07060.x","article-title":"Assembly of nicotinic and other Cys-loop receptors","volume":"116","author":"Tsetlin","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0180","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-065X.1998.tb01190.x","article-title":"Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor","volume":"163","author":"Tzartos","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0190","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0195","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1537-2995.1982.22182154218.x","article-title":"Changes in coagulation factors, complement, immunoglobulins, and immune complex concentrations with plasma exchange","volume":"22","author":"Volkin","year":"1982","journal-title":"Transfusion"},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2369-15-128","article-title":"Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis","volume":"15","author":"Zhang","year":"2014","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.jneuroim.2017.09.001_bb0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.06.002","article-title":"Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains","volume":"200","author":"Zisimopoulou","year":"2008","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817303326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817303326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:27Z","timestamp":1759048167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572817303326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":42,"alternative-id":["S0165572817303326"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.09.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}